The vision of Passage Bio is to become the premier genetic medicines company by developing and ultimately commercializing therapies that dramatically and positively transform the lives of patients suffering from rare, monogenic CNS disorders
Founded by proven industry veterans, Passage is built on cutting edge innovation in the field of genetic medicine research